The World Vitiligo Day (WVD) Committee proudly announces the Colombia as the host for WVD 2024. This momentous event will be held under the esteemed honorary presidency of Dr. Rafael Falabella, a distinguished figure in dermatology and skincare research, and Adriana Cruz as Secretary General.

Each year, the international campaign's headquarters shift from one country to another, maximising its global reach. National events in the USA migrate between states annually, whereas in countries like China and India, WVD events are traditionally held in the same location, reflecting local customs and continuity. For more details, check the brief history of the campaign.

• 2024: 🇨🇴 Cali, Colombia 
• 2023: 🇰🇿 Almaty, Kazakhstan 
• 2022: 🇲🇽 Mexico City, Mexico 
• 2021: 🇮🇩 Jakarta, Indonesia 
• 2020: 🇷🇸 Zagreb, Serbia 
• 2019: 🇻🇳 Hanoi, Vietnam 
• 2018: 🇺🇸 Boston, USA 
• 2017: 🇧🇷 Sao Paulo, Brazil 
• 2016: 🇨🇿 Prague, the Czech Republic 
• 2015: 🇨🇳 Shenyang, China 
• 2014: 🇮🇳 Chandigarh, India 
• 2013: 🇺🇸 Detroit, USA 
• 2012: 🇮🇹 Rome, Italy (official launch)
• 2011: 🇳🇬 Lagos, Nigeria (Purple Fun Day)

WVD capital is thoughtfully chosen by the WVD Presidential Committee, which reviews proposals from candidate cities before the end of the current year. Although the inaugural event in Nigeria was celebrated under the banner of 'Purple Fun Day' in 2011, we proudly acknowledge Lagos as an honorary first WVD capital.

As we embark on the exciting journey to the World Vitiligo Day 2024 ahead, we extend our heartfelt gratitude to  WVD 2023 team in Kazakhstan, led by Drs. Aliya Kassymkhanova and Anar Abdrakhmanova. They achieved unprecedented media coverage and successfully integrated multiple Kazakh cities into the campaign, setting new benchmarks for World Vitiligo Day. 

Over the years, the global campaign has significantly increased awareness and understanding of vitiligo, leading to greater public interest and media coverage. It has also successfully engaged 'Big Pharma' in drug development for vitiligo, with the first FDA-approved drug and a few more in the late stages of development.